2025 APASL | 中国科研力量大放异彩,近两百篇肝胆胰肿瘤Poster抢先看!

360影视 日韩动漫 2025-03-12 22:03 2

摘要:第34届亚太肝脏研究协会(Asian-Pacific Association for the Study of the Liver,APASL)年会将于3月26日至3月30日在北京盛大启幕。目前会议摘要标题已公布,医脉通肿瘤科特别整理了肝胆胰肿瘤领域的中国Po

第34届亚太肝脏研究协会(Asian-Pacific Association for the Study of the Liver,APASL)年会将于3月26日至3月30日在北京盛大启幕。目前会议摘要标题已公布,医脉通肿瘤科特别整理了肝胆胰肿瘤领域的中国Poster研究,与读者一同抢先聆听中国强音的前奏。

标题:Mortality Burden of HBV/HCV-related Liver Cancer: A Comparative Analysis of Temporal and Spatial Trends from 1990 to 2050

报告人:Yujiao Deng

New-ID:PP0030

标题:A persistent global inequality in HBV-related liver cancer burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021

报告人:He Li

03 Submit ID:15383

New-ID:PP0031

标题:Global Distribution and Trends of Liver Cancer due to Nonalcoholic Steatohepatitis from 1990-2021

报告人:Gang Qin

04 Submit ID:15573

New-ID:PP0032

标题:Estimates and trends in the global burden of hepatocellular carcinoma by NASH from GBD Study between 1990 to 2021

报告人:Jing Liu

05 Submit ID:16296

New-ID:PP0034

标题:The disease burden of gallbladder and biliary tract cancer from 1990-2021: a population-based observational study from 2021 GBD database

报告人:Xiaoxiao Wang

06 Submit ID:16040

New-ID:PP0038

标题:An Analysis of Gender, Age Distribution, and Temporal Trends in Cholangiocarcinoma Mortality in the United States: A Population-based Study

报告人:Xindi Huang

07 Submit ID:15104

New-ID:PP0058

标题:Study on the synergistic mechanism of photodynamic therapy combined with ferroptosis inducer to induce ferroptosis in cholangiocarcinoma

报告人:Sifan Dong

08 Submit ID:15994

New-ID:PP0077

标题:Expression of ORC1 Gene in the Histology of HBV-associated Hepatocellular Carcinoma

报告人:Qingmei Li

09 Submit ID:14124

New-ID:PP0078

标题:The association of hepatitis B virus with extrahepatic tumors, mainly pancreatic cancer

报告人:Yuchao Lu

10 Submit ID:16063

New-ID:PP0127

标题:Correlation Analysis Between HBV DNA and cccDNA Levels in Liver Tissues of HBV-HCC Patients and Tumor Markers

报告人:Jin Li

11 Submit ID:16600

New-ID:PP0134

标题:Risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance and a novel prediction model establishment

报告人:Shuaibing Ying

12 Submit ID:11500

New-ID:PP0144

标题:Correlation between FIB-4 index and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A prospective cohort study

报告人:Xuesong Gao

13 Submit ID:11655

New-ID:PP0145

标题:Dynamic assessment of liver steatosis on the risk of hepatocellular carcinoma in patients with chronic hepatitis B by ultrasound

报告人:Mingyue Xiao

14 Submit ID:12151

New-ID:PP0151

标题:Establishment of a Bile Acid-based Risk Model to Predict the Progression to Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B

报告人:Xue mei Zhang

15 Submit ID:12993

New-ID:PP0153

标题:To Explore the Relationship between ESPL1 Gene and p53 Gene in HCC Patients and to Analyze Its Diagnostic Value for HCC

报告人:Yanfei Feng

16 Submit ID:16213

New-ID:PP0225

标题:HBV screening, diagnosis and treatment model for family members of HBV-related HCC patients

报告人:Peng Wang

17 Submit ID:15984

New-ID:PP0245

标题:Effectiveness and Safety of 48-Week Tenofovir Amibufenamide in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Real-World Study

报告人:Qinglei Zeng

18 Submit ID:16105

New-ID:PP0247

标题:Expression of CD161+CD8+ T Cells in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma

报告人:刘晨瑞

单位:西安交通大学第二附属医院

19 Submit ID:16216

New-ID:PP0250

标题:The diagnostic value of serum CHI3L1 in the progression of chronic liver disease and prognosis of liver cancer

报告人:Haiying Zhang

20 Submit ID:14121

New-ID:PP0262

标题:Identification of RAD51AP1 as a Key Gene in Hepatitis B Virus-Associated Hepatocellular Carcinoma

报告人:Changfeng Sun

21 Submit ID:14812

New-ID:PP0266

标题:ORC1 Protein as a Serum Marker of HBV-associated Hepatocellular Carcinoma

报告人:Su Tumei

22 Submit ID:13735

New-ID:PP0285

标题:The Risk Factors Associated with Liver Cancer and Cirrhosis in Chronic Hepatitis C Patients and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment

报告人:Jinsheng Guo

23 Submit ID:15964

New-ID:PP0294

标题:Mendelian randomization analysis reveals Hepatitis C infection is causally associated with extrahepatic cancer

报告人:刘长青

单位:北京大学肿瘤医院

24 Submit ID:13586

New-ID:PP0380

标题:Trans Fatty Acids Regulate the Growth and Proliferation of Hepatocellular Carcinoma Cells via the OPN-NF-κB Signaling Axis

报告人:Peici Yan

25 Submit ID:14053

New-ID:PP0384

标题:Trans Fatty Acids Induce the Construction of HCC-Microenvironment by Accelerating the Process of Liver Fibrosis

报告人:Xiangnan Wang

26 Submit ID:15529

New-ID:PP0414

标题:CD133 drives MASLD-related hepatocellular carcinoma and is a therapeutic target

报告人:Yasi PAN

27 Submit ID:15724

New-ID:PP0518

标题:The Influence of Metabolic Dysfunction-Associated Fatty Liver Disease on the Risk of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis B

报告人:Zixiang Huang

28 Submit ID:16575

New-ID:PP0526

标题:Histone Methylation as a Biomarker for MASH Progression to Hepatocellular Carcinoma

报告人:Xinlei Qi

29 Submit ID:11807

New-ID:PP0571

标题:APRI can be used as an effective predictor of liver injury in patients with hepatocellular carcinoma treated with PD-1/PD-L1 inhibitor combination therapy:A single-center retrospective study

报告人:JingMing Zhang

30 Submit ID:16266

New-ID:PP0645

标题:Single-Cell RNA Sequencing for a Rare Case of Primary Biliary Cholangitis-Associated Hepatocellular Carcinoma Reveals a Distinct Immune Landscape and Potential Therapeutic Targets

报告人:Jie Han

31 Submit ID:16719

New-ID:PP0800

标题:中医外治法治疗肝癌介入术后呃逆的研究

报告人:wei xiao guo

32 Submit ID:11785

New-ID:PP0815

标题:Avatrombopag for the treatment of immune checkpoint inhibitor/targeted therapy-related thrombocytopenia in patients with hepatocellular carcinoma: A prospective, multicenter, single-arm trial

报告人:Wang Yong Shuai

33 Submit ID:14824

New-ID:PP0915

标题:Endoscopic treatment as secondary prophylaxis ameliorates short-term mortality for acute esophagogastric variceal bleeding in older patients with cirrhotic hepatocellular carcinoma

报告人:Qi Li

34 Submit ID:13842

New-ID:PP0940

标题:Spatial Transcriptomics Integrated with Bulk RNA Sequencing Reveals the Prognostic Signatures and Immunoinfiltration in Hepatocellular Carcinoma Undergoing Immunotherapy, and Construction of Related Predictive Models Using Machine Learning

报告人:zhenyu zheng

35 Submit ID:16596

New-ID:PP0942

标题:Protein C Licenses P62/mTOR-Mediated Autophagy Activation to Drive Hepatocellular Carcinoma Progression

报告人:Shuaibing Ying

36 Submit ID:11336

New-ID:PP0943

标题:LHX3 promotes EMT process in hepatoma cell through β-catenin/TCF4 pathway

报告人:Zhonglan You

37 Submit ID:13366

New-ID:PP0944

标题:LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation

报告人:YIngchao Wang

38 Submit ID:11742

New-ID:PP0945

标题:Efficacy and safety analysis of transarterial chemoembolization plus donafenib with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a prospective, single-arm, single-center, phase II clinical study

报告人:Jinpeng Li

39 Submit ID:12904

New-ID:PP0947

标题:FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription

报告人:Yuqing Xie

40 Submit ID:12929

New-ID:PP0948

标题:XPD inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells and its related mechanisms

报告人:Jie Jian

41 Submit ID:11436

New-ID:PP0949

标题:Short-term Efficacy and Safety Analysis of HAIC Combined with Targeted and Immunotherapy for Unresectable Hepatocellular Carcinoma with High-flow Hepatic Arteriovenous Fistula

报告人:Jinpeng Li

42 Submit ID:13371

New-ID:PP0950

标题:Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: Clinical implications

报告人:YIngchao Wang

43 Submit ID:13384

New-ID:PP0951

标题:Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma

报告人:Bixing Zhao

44 Submit ID:14113

New-ID:PP0952

标题:Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights from Super and Poor Survivors with Prognostic Signature Identification

报告人:Xiaoqian Xu

45 Submit ID:14116

New-ID:PP0953

标题:Role of the nucleotide excision repair function of CETN2 in the inhibition of the sensitivity of hepatocellular carcinoma cells to oxaliplatin

报告人:Hengcheng Tang

46 Submit ID:14205

New-ID:PP0954

标题:Weissella confusa inhibits liver cancer lung metastasis by suppressing the secretion of ursodeoxycholic acid (UDCA)

报告人:Shuang Li

47 Submit ID:14470

New-ID:PP0955

标题:The Chinese herbal KangXianYiAi formula attenuates hepatocellular carcinoma by regulating the bile acid transporters and YAP expression

报告人:xiaobin Zao

48 Submit ID:14628

New-ID:PP0956

标题:Sinomenine Reduces the Proliferative Activity of Hepatocellular Carcinoma by Inhibiting Trim29 Expression

报告人:Jingjing He

49 Submit ID:14802

New-ID:PP0957

标题:Hu-Qi-San suppresses Sgp19-KRas intrahepatic cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment

报告人:Huang Xiuqin

50 Submit ID:15012

New-ID:PP0958

标题:High-resolution Quantitative Reconstruction of Microvascular Architectures in Mouse Hepatocellular Carcinoma Models

报告人:Yan Zhao

51 Submit ID:13342

New-ID:PP0960

标题:The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination

报告人:Peng Chen

52 Submit ID:15298

New-ID:PP0961

标题:ACSS2-induced Acetyl-CoA accumulation and H3K27ac promotes VDAC1-mediated mitophagy and tumor growth in Hepatitis B virus-associated hepatocellular carcinoma

报告人:Shan Li

53 Submit ID:15814

New-ID:PP0965

标题:Integrated single-cell and spatial transcriptome reveal the intracellular and extracellular roles of tumor cell-derived osteopontin in promoting intrahepatic cholangiocarcinoma progression

报告人:Yuan Liang

54 Submit ID:13157

New-ID:PP0966

标题:Tumor Shrinkage Following Epclusa Treatment: Exploring Potential Role of Direct-Acting Antivirals in HCV-Related Hepatocellular Carcinoma

报告人:Haipeng Jiang

55 Submit ID:15142

New-ID:PP0967

标题:The status of cytotoxic lymphocytes before transarterial chemoembolization plus systemic terapies serves as an indicator of therapeutic efficacy and prognosis in patients with advanced hepatocellular carcinoma

报告人:Haifeng Zhou

56 Submit ID:16208

New-ID:PP0969

标题:High chloride intake inhibits the carcinogenesis and growth of hepatocellular carcinoma

报告人:Li Zhang

57 Submit ID:15516

New-ID:PP0970

标题:Up-regulated Krüppel-like factor 5 Promotes Hepatocellular Carcinoma Progression via Activating Wnt3a Signaling

报告人:Wenli Sai

58 Submit ID:16614

New-ID:PP0971

标题:Development and validation of functional liver imaging score model to predict prognosis of patients with hepatocellular carcinoma after surgical resection

报告人:Xinya Zhao

59 Submit ID:11335

New-ID:PP0973

标题:Combined DeRitis ratio and alkaline phosphatase on the Prediction of Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma

报告人:苗同国

单位:石家庄市第五医院

60 Submit ID:11716

New-ID:PP0974

标题:Development and Validation of an ESPL1-Based Risk Model for Early Detection of HBV-Related Hepatocellular Carcinoma

报告人:Luhuai Feng

61 Submit ID:13020

New-ID:PP0975

标题:Gadoxetic acid disodium (Gd-EOB-DTPA) contrast-enhanced abbreviated magnetic resonance imaging (MRI) for hepatocellular carcinoma surveillance in at-risk patients: a multi-center study in China

报告人:Lan Zhang

62 Submit ID:15447

New-ID:PP0976

标题:Extracellular volume (ECV) derived from spectral CT to assess vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study

报告人:Yongquan Yu

63 Submit ID:13023

New-ID:PP0977

标题:Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus

报告人:Lan Zhang

64 Submit ID:14223

New-ID:PP0978

标题:Construction and evaluation of prognostic model of liver cancer based on triple serum fluorescence indicator of aptamer

报告人:Jianming Zhou

65 Submit ID:14306

New-ID:PP0979

标题:A Digital Risk Stratification Management Platform Based on GAAD Score Improves the Early Diagnosis of Hepatocellular Carcinoma (HCC) through Screening Chronic Hepatitis B (CHB) Patients: A Real-World Study in China

报告人:Yong Li

66 Submit ID:14310

New-ID:PP0980

标题:Causal Associations between Sarcopenia-Related Traits and Primary Liver Cancer in the European Population: A Mendelian Randomization Study

报告人:Zuohu Niu

67 Submit ID:13022

New-ID:PP0981

标题:Differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma based on MRI correlated with serum tumor markers: A multi-center study in China

报告人:Lan Zhang

68 Submit ID:15432

New-ID:PP0982

标题:A nomogram model for predicting the survival of patients with alcohol-related hepatocellular carcinoma

报告人:Chang Guo

699

Submit ID:15495

New-ID:PP0983

标题:Comparison of Hotgen Biotech and Abbott Architect in Measuring AFP and PIVKA-II for Hepatocellular Carcinoma Diagnosis

报告人:YUAN HUANG

70 Submit ID:15765

New-ID:PP0984

标题:A nomogram based on clinical indicators and enhanced CT for prediction of VETC metastatic pattern in hepatocellular carcinoma

报告人:Yongquan Yu

71 Submit ID:15798

New-ID:PP0985

标题:Dynamic PET/CT images and deep learning assessment for early diagnosis of liver cancer induced by DEN/CCl4 in mice

报告人:Junnan Wang

72 Submit ID:15798

New-ID:PP0986

标题:Radiographic response combined Radiomic features response predict pathologic complete response to systemic therapy in hepatocellular carcinoma

报告人:ShiQi Zhou

73 Submit ID:11672

New-ID:PP0994

标题:Myasthenia gravis-like symptoms following immune checkpoint inhibitor therapy for hepatocellular carcinoma: a case report

报告人:Fushuang Ha

74 Submit ID:12854

New-ID:PP0995

标题:Developing a signature based on necroptosis-related lncRNAs to predict the prognosis and immunotherapy response of hepatocellular carcinoma

报告人:Yao Liu

75 Submit ID:13292

New-ID:PP0996

标题:ERAL1 down-regulates NDUFV1 through m6A reader IGF2BP2 to inhibit mitochondrial ATP synthesis and metastasis in hepatoma cells

报告人:Li Zhou

76 Submit ID:13992

New-ID:PP0998

标题:Risk Factors for Early-Onset HCC in Patients with HBV Infection

报告人:关玉娟

单位:广州医科大学附属市八医院

77 Submit ID:14450

New-ID:PP0999

标题:Lipid Phosphatase SAC1 Suppresses the Metastasis of Hepatocellular Carcinoma by Dual Activation of PI4P/NF2-MST1/2-LAST1/2-YAP Axis and Promoting YAP Cytoplasmic Retention through Interacting with 14-3-3

报告人:Haihuan Tang

78 Submit ID:15105

New-ID:PP1003

标题:Conversion therapy and R0 resection for pancreatic cancer with multiple liver metastases:A case report

报告人:an jiang

79 Submit ID:15127

New-ID:PP1004

标题:Analysis on clinicopathological characteristics and prognostic factors of gallbladder carcinoma from adenoma

报告人:Ruiqi Zou

80 Submit ID:16385

New-ID:PP1006

标题:Construction and validation of a novel recurrence risk model for postoperative patients with stage I intrahepatic cholangiocarcinoma

报告人:Hui Wang

81 Submit ID:15436

New-ID:PP1007

标题:Efficacy and safety in Advanced Cholangiocarcinoma Using different doses of Lenvatinib Combined with PD-1 and GEMOX:A Retrospective Analysis of Real-World Evidence

报告人:Jiamin Chen

82 Submit ID:15128

New-ID:PP1008

标题:Clinicopathological Features and Survival Outcomes of Pure Gallbladder Squamous Cell Carcinoma: A China experience

报告人:RuiQi Zou

83 Submit ID:16383

New-ID:PP1010

标题:Mediation analysis of surgery in prognosis among postoperative intrahepatic cholangiocarcinoma patients

报告人:Hui wang

84 Submit ID:13379

New-ID:PP1013

标题:ASAP Score as a Novel Prognostic Tool for Recurrence and Survival in Hepatitis B-related Hepatocellular Carcinoma Following Curative Resection

报告人:杨田

单位:海军军医大学第三附属医院(东方肝胆外科医院)

85 Submit ID:16587

New-ID:PP1014

标题:Profiling the Roles of MicroRNAs Associated with Cancer Stem Cells, Drug Resistance, Metastasis, and Recurrence in Hepatocellular Carcinoma: A Systematic Review, Network analysis, and Experimental Initial Verification

报告人:Yuanyuan Jiang

86 Submit ID:16598

New-ID:PP1015

标题:The Role and Mechanisms of PYCR1 in Regulating Proline Biosynthesis Through Metabolic Pathways in the Development of Intrahepatic Cholangiocarcinoma

报告人:Xincheng Xie

87 Submit ID:16628

New-ID:PP1016

标题:Mechanisms of Hepatic Progenitor Cell Aberrant Differentiation into Cancer: Factors Influencing the Transition from Cell Differentiation to Tumorigenesis

报告人:Leyi Li

88 Submit ID:14332

New-ID:PP1017

标题:Tumor Biology Characteristics Score Based on AFP and PIVKA-II Predicts Recurrence and Survival After Curative Resection for Hepatocellular Carcinoma

报告人:杨田

单位:海军军医大学第三附属医院(东方肝胆外科医院)

89 Submit ID:11416

New-ID:PP1018

标题:AKR1D1 represses hepatocellular carcinoma progression and immune evasion by reprogramming fatty acid metabolism via STAT3

报告人:Yuxi Lin

90 Submit ID:11721

New-ID:PP1019

标题:Expression of ESPL1 gene in HBV-associated HCC cancer tissues and its relationship with tumor pathological features

报告人:Qianbing Yin

91 Submit ID:11750

New-ID:PP1020

标题:Expression of NOP2 in Hepatocellular Carcinoma and Its Effects on the Proliferation, Migration, and Invasion of Liver Cancer

报告人:Hao Ding

92 Submit ID:12558

New-ID:PP1021

标题:Expression of the FCGBP Gene in Hepatocellular Carcinoma Tissues and Its Role in Prognostic Assessment

报告人:Hang Wang

93 Submit ID:12675

New-ID:PP1022

标题:Investigation of the Expression and Spatial Distribution of Acylglycerol Kinase in patients with HCC and Its Prognosis Significance

报告人:Gaixia He

94 Submit ID:12847

New-ID:PP1023

标题:PPARγ-ELOVL1-16:0-PPARγ-STIP1 as a Mechanotransduction Pathway Promoting HCC

报告人:Xingyuan Chen

95 Submit ID:13011

New-ID:PP1024

标题:The Aging and Metabolic Characteristics of Hepatocellular Carcinoma were Analyzed and The Prognostic Model was Established Based on TCGA Database

报告人:Mengru Hua

96 Submit ID:13012

New-ID:PP1025

标题:Causal Role of Immune Cells in Hepatocellular Carcinoma: a bidirectional mendelian randomization study

报告人:Yuting Liu

97 Submit ID:13017

New-ID:PP1026

标题:STAB1+ Senescent Macrophages Are Driven to Infiltrate and Uniquely Shape an Immunosuppressive Microenvironment in Hepatocellular Carcinoma

报告人:Longyang Zhou

98 Submit ID:13070

New-ID:PP1027

标题:Hepatitis B Doubly Spliced Protein (HBDSP) Promotes Migration and Invasion in Hepatoma Cells by Up-regulating YAP Expression in Epithelial-Mesenchymal Transition (EMT)

报告人:Xiazhen Xu

99 Submit ID:16754

New-ID:PP1028

标题:Causal relationship between gut microbiota and hepatocellular carcinoma: A Mendelian randomization and case-control study

报告人:LIANG XU

100

Submit ID:13648

New-ID:PP1029

标题:AHCTF1 functions as an oncogenic factor and promotes tumor progression in hepatocellular carcinoma

报告人:Zhang Nuobei

101

Submit ID:13727

New-ID:PP1030

标题:The macrophage cytoskeletal protein AIF1 contributes to the immunosuppressive microenvironment in hepatocellular carcinoma by upregulating SPP1

报告人:Hao Cai

102

Submit ID:13814

New-ID:PP1031

标题:Endoscopic treatment as secondary prophylaxis ameliorates short-term mortality for acute esophagogastric variceal bleeding in older patients with cirrhotic hepatocellular carcinoma

报告人:Hongyan Huang

103

Submit ID:14074

New-ID:PP1033

标题:p53-regulated tsRNA-6 promotes proliferation in HCC cells by mediating DNA homologous recombination repair

报告人:Guanzi Chen

104

Submit ID:14119

New-ID:PP1034

标题:N4BP2L1 Inhibits Glycolysis in Hepatocellular Carcinoma Cells by Promoting Ubiquitination of HIF-1α

报告人:Xiaoling Liu

105

Submit ID:14271

New-ID:PP1035

标题:Dual Prognostic Impact of Preoperative Platelet Count Abnormalities on Long-term Oncologic Outcomes After Hepatic Resection for Hepatocellular Carcinoma: Insights from A Multicenter Analysis of 3,116 Patients

报告人:杨田

单位:海军军医大学第三附属医院(东方肝胆外科医院)

106

Submit ID:14459

New-ID:PP1036

标题:NOL9 Regulates β-Catenin Stability and Ribosome Biogenesis in Hepatocellular Carcinoma

报告人:Xiyao Chen

107

Submit ID:14749

New-ID:PP1037

标题:Bioinformatic Analysis of Macrophage Polarization and RNA Methylation-Associated Differentially Expressed Genes in Hepatocellular Carcinoma

报告人:KONGLI FAN

108

Submit ID:14821

New-ID:PP1038

标题:Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression

报告人:Lang Chen

109

Submit ID:15901

New-ID:PP1039

标题:Identification of Gut Microbiota and Bile Acid Metabolite Signatures for Predicting Response to Lenvatinib and Anti-PD-1 Combination Therapy in Hepatocellular Carcinoma

报告人:Jie Han

110

Submit ID:16295

New-ID:PP1040

标题:Prognostic value of N1/N2 neutrophils heterogeneity and tertiary lymphoid structure in hepatocellular carcinoma patients

报告人:Yanfei Lang

111

Submit ID:15579

New-ID:PP1041

标题:The Role of DDX10 in Hepatocellular Carcinoma Metastasis: Regulation of Ferroptosis

报告人:Mingyu Zhang

112

Submit ID:16049

New-ID:PP1042

标题:COMPREHENSIVE ANALYSIS OF THE ROLE OF TUMOR-ASSOCIATED ANTI-SMGGDS AUTOANTIBODY IN HEPATOCELLULAR CARCINOMA

报告人:WEI HOU

113

Submit ID:15427

New-ID:PP1043

标题:The mechanism of m5C methylation regulated energy metabolic reprogramming of hepatocellular carcinoma mediated by ALYREF/UGP2 signaling axis involved in tumor progression

报告人:JUAN LU

114

Submit ID:15590

New-ID:PP1044

标题:The Mechanism of Metabotropic Glutamate Receptor 5 in the Tumorigenesis, Progression and Angiogenesis of Hepatocellular Carcinoma

报告人:Jing Li

115

Submit ID:15922

New-ID:PP1045

标题:Comparison of platelet count and function between hepatocellular carcinoma and liver cirrhosis

报告人:Meng Zhang

116

Submit ID:16140

New-ID:PP1046

标题:A PAN-CANCER ANALYSIS OF THE ROLE OF ZC3HAV1 IN HUMAN CANCERS

报告人:WEI HOU

117

Submit ID:16371

New-ID:PP1047

标题:KRI1 Promotes Hepatocellular Carcinoma Progression by Affecting the Structure and Function of Nucleoli through Liquid-Liquid Phase Separation

报告人:Yu Lu

118

Submit ID:16274

New-ID:PP1048

标题:PAN‑CANCER ANALYSIS OF CAMSAP FAMILY AND UNRAVELLING THE ONCOGENIC ROLE IN HEPATOCELLULAR CARCINOMA

报告人:WEI HOU

119

Submit ID:15980

New-ID:PP1050

标题:AN INTEGRATED ANALYSIS OF THE ROLE OF tsRNA-Thr-5-0015 IN HUMAN TUMORS ACROSS MULTIPLE CANCER TYPES

报告人:WEI HOU

120

Submit ID:14703

New-ID:PP1051

标题:Development and validation of pyruvate metabolism associated gene signatures to predict prognosis and immunotherapy response in hepatocellular carcinoma

报告人:Ning Wang

121

Submit ID:16190

New-ID:PP1052

标题:INTEGRATED BIOINFORMATIC ANALYSIS OF THE ROLE OF WNK1 IN HEPATOCELLULAR CARCINOMA

报告人:WEI HOU

122

Submit ID:15180

New-ID:PP1053

标题:Matrine improves sorafenib resistance in hepatocellular carcinoma by regulating cell cycle, mitochondrial function, and epithelial-mesenchymal transition through inhibiting the Notch1 signaling pathway

报告人:Man Zhao

123

Submit ID:16567

New-ID:PP1054

标题:Hepatic Arterial Infusion Chemotherapy with mFOLFOX in Advanced Gallbladder Cancer: An Approach with Potential for Conversion and Enhanced Survival

报告人:Liu Ying

124

Submit ID:11675

New-ID:PP1056

标题:Comparison of the efficacy and safety of HAIC combined with Camrelizumab and Apatinib versus TACE in the treatment of intermediate-advanced HCC

报告人:Haojie Zhang

125

Submit ID:13090

New-ID:PP1057

标题:Transcatheter arterial chemoembolization combined with immune checkpoint inhibitors plus molecular targeted therapy after 125I irradiation stent placement in patients with hepatocellular carcinoma and main portal vein tumor thrombosis: a multicenter prope

报告人:Junhao Mei

126

Submit ID:13546

New-ID:PP1058

标题:Research Trends and Hotspots in Copper Metabolism in Hepatocellular Carcinoma: A Visual Analysis Based on Web of Science

报告人:Yi Zhang

127

Submit ID:13768

New-ID:PP1059

标题:Prediction of Response to Hepatic Arterial Infusion of Raltitrexed and Oxaliplatin (Ralox-HAIC) combined with lenvatinib and camrelizumab for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Prospective, Single-arm clinical study

报告人:袁国盛

单位:南方医科大学南方医院

128

Submit ID:13858

New-ID:PP1060

标题:Evaluation of the efficacy of interventional therapy combined with/without targeted and immunotherapy in patients with Child-Pugh B hepatocellular carcinoma and analysis of the beneficiary population: a single-center, retrospective study

报告人:Xuwei Guo

129

Submit ID:14062

New-ID:PP1061

标题:Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma

报告人:Quan Wang

130

Submit ID:14720

New-ID:PP1062

标题:Efficacy of sequential radiotherapy after the combination of transcatheter arterial chemoembolization with lenvatinib and anti-PD-1 antibodies for unresectable hepatocellular carcinoma

报告人:Xiangye Ou

131

Submit ID:14453

New-ID:PP1063

标题:Impact of Switching from ETV to TDF or TAF on the 3-Year Recurrence Rate After RFA Treatment in HBV-Related HCC Patients

报告人:Xue Zhang

132

Submit ID:14813

New-ID:PP1064

标题:Prognostic Value of Systemic Immune-Inflammatory Index Combined with Prognostic Nutritional Index in Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization, Lenvatinib and PD-1 Inhibitors

报告人:Zhenxin Zeng

133

Submit ID:15435

New-ID:PP1069

标题:Efficacy and Safety of Regorafenib vs. Regorafenib Combined with PD-1 Inhibitors as a Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma:A Retrospective Analysis of Real-World Evidence

报告人:Weihong Ma

134

Submit ID:15434

New-ID:PP1071

标题:Survival analysis of hepatic arterial infusion chemotherapy on progression-free survival in advanced hepatocellular carcinoma with portal vein tumor thrombus

报告人:Mengwen He

135

Submit ID:15355

New-ID:PP1072

标题:Peripheral immune features synergizing neutrophil-to-lymphocyte ratio in prediction of poor survival of hepatocellular carcinoma after thermal ablation

报告人:Fangying Fan

136

Submit ID:16469

New-ID:PP1073

标题:Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration

报告人:Donghao Yin

137

Submit ID:16588

New-ID:PP1074

标题:“白花蛇舌草-半枝莲”治疗原发性肝癌的机制研究:基于网络药理学、分子对接及体外实验验证

报告人:徐朦

单位:南方医科大学

138

Submit ID:16571

New-ID:PP1075

标题:Decoding Glycogen Metabolism in HCC: A novel Prognostic Biomarkers and Therapeutic Targets

报告人:Anna Li

139

Submit ID:16744

New-ID:PP1076

标题:Long-term Prognostic Impact of Traditional Chinese Medicine on Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Retrospective Cohort Study

报告人:ping xue zhang

140

Submit ID:16624

New-ID:PP1077

标题:Impact of Aerobic Glycolysis on the Tumor Microenvironment in Hepatocellular Carcinoma

报告人:Mengzhuo Liu

141

Submit ID:16584

New-ID:PP1078

标题:Adjuvant transarterial chemoembolization after truly curative resection does not improve survival of patients with hepatocellular carcinoma at high risk of recurrence: a target trial emulation study

报告人:钟鉴宏

单位:广西医科大学附属肿瘤医院

142

Submit ID:11833

New-ID:PP1079

标题:ERRα promotes HCC cell progression via PHF5A/PI3K/AKT signaling pathway

报告人:Xiang Cai

143

Submit ID:11916

New-ID:PP1080

标题:Single-cell RNA sequencing revealed that the enrichment of TPI1+ malignant hepatocytes was linked to HCC metastasis and immunosuppressive microenvironment

报告人:Yuxin Liang

144

Submit ID:12877

New-ID:PP1081

标题:Impact of Jinlong Capsule on Prognosis of Patients with Hepatocellular Carcinoma: A Propensity Score Matching Study

报告人:Ke Shi

145

Submit ID:12903

New-ID:PP1082

标题:Novel cellular senescence related molecular subtypes and prognostic characteristics of hepatocellular carcinoma

报告人:Yuling Liang

146

Submit ID:12908

New-ID:PP1083

标题:raditional Chinese Medicine in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

报告人:Wanxin Shi

147

Submit ID:13816

New-ID:PP1084

标题:Preoperative Prognostic Model Combining Tumor Burden Score and Tumor Markers to Predict Long-term Outcomes Following Hepatectomy for Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis

报告人:JUN FU

148

Submit ID:14486

New-ID:PP1085

标题:Glycodeoxycholic acid stimulates antitumor immune response by driving macrophages toward M1 phenotype in hepatocellular carcinoma

报告人:Mingxia Deng

149

Submit ID:14780

New-ID:PP1086

标题:

Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma

报告人:Xiaoli Zhang

150

Submit ID:15059

New-ID:PP1087

标题:A m6A-Altering Variant of MRPL34 Predisposes to Hepatocellular Carcinoma via Regulating Oxidative Phosphorylation

报告人:Jiaxuan Chen

151

Submit ID:15203

New-ID:PP1089

标题:A case of intrahepatic bile duct papillary tumor with invasive adenocarcinoma

报告人:Linhui Hu

152

Submit ID:14359

New-ID:PP1091

标题:Impact of Regular Surveillance Compliance on Survival Outcomes After Curative Resection for Hepatocellular Carcinoma

报告人:杨田

单位:海军军医大学第三附属医院(东方肝胆外科医院)

153

Submit ID:16684

New-ID:PP1092

标题:Hepatic arterial infusion chemotherapy sequential transarterial embolization combined with lenvatinib and tislelizumab in patients with high-risk unresectable hepatocellular carcinoma: an update analysis of a phase 2 trial

报告人:钟鉴宏

单位:广西医科大学附属肿瘤医院

154

Submit ID:16712

New-ID:PP1093

标题:Risk Factors for Extrahepatic Metastasis after Microwave Ablation of Hepatocellular Carcinoma

报告人:Xueqin Tian

155

Submit ID:13818

New-ID:PP1094

标题:A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma

报告人:JUN FU

156

Submit ID:14827

New-ID:PP1095

标题:Case Report: Laparoscopic Hepatectomy for Recurrent Hepatocellular Carcinoma Following Two Previous Surgical Interventions

报告人:Chenfenglin Yang

157

Submit ID:14058

New-ID:PP1096

标题:Safety and Efficacy of Cryoablation Plus Lenvatinib versus TACE Plus Lenvatinib in Unresectable Hepatocellular Carcinoma

报告人:常秀娟

单位:中国人民解放军总医院第五医学中心

158

Submit ID:14833

New-ID:PP1097

标题:Case Report: Surgical Management of Synchronous Double Primary Cancers in the Liver and Duodenum

报告人:Chenfenglin Yang

159

Submit ID:15302

New-ID:PP1099

标题:Novel LPS-A4 score as a predictive model of hepatocellular carcinoma development in patients with chronic hepatitis B

报告人:Jingjing Song

160

Submit ID:15233

New-ID:PP1100

标题:The 15-year Prognostic Analysis of Solitary Hepatocellular Carcinoma No More Than 5cm Treated by Microwave Ablation : Primary HCC versus Local Tumor Progression

报告人:Yannan Qiao

161

Submit ID:15750

New-ID:PP1101

标题:Exosome miR-509-3p as a Novel Therapeutic Strategy Inhibits Metastasis of Hepatocellular Carcinoma via APOD/Wnt2B signaling pathway

报告人:Tao Li

162

Submit ID:16722

New-ID:PP1102

标题:TACE with or without Lenvatinib as Adjuvant Therapy for HCC with microvascular invasion (MVI) or Portal Vein Thrombus(Cheng’s I/II):A Single-Center, Prospective, Non-Randomized Cohort Study

报告人:朱成佩

单位:首都医科大学附属北京佑安医院

163

Submit ID:15264

New-ID:PP1103

标题:Survival benefit of hepatectomy after complete or partial response to conversion therapy in unresectable hepatocellular carcinoma: a multi-center study

报告人:DaLong Yang

164

Submit ID:16427

New-ID:PP1104

标题:Reversal of CD8+ T Cell Exhaustion Phenotype in Hepatocellular Carcinoma Models by Yangyin-Fuzheng-Jiedu Formula

报告人:Zimeng Shang

165

Submit ID:16667

New-ID:PP1106

标题:Multi-kingdom gut microbiota in predicting severe immune-related adverse events in advanced hepatobiliary cancers

报告人:朱成佩

单位:首都医科大学附属北京佑安医院

166

Submit ID:16671

New-ID:PP1107

标题:Traditional Chinese Medicine in Patients with Hepatocellular Carcinoma and anemia

报告人:Wanxin Shi

167

Submit ID:12336

New-ID:PP1108

标题:Efficacy and Safety of Transcatheter Arterial Chemoembolisation Combined with Lenvatinib plus Anti-PD1 Inhibitors versus Transcatheter Arterial Chemoembolisation Alone for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

报告人:Xiangye Ou

168

Submit ID:14139

New-ID:PP1110

标题:Combining with immunotherapy is a promising modality of regorafenib treatment in patients with unresectable hepatocellular carcinoma

报告人:李天翔

单位:青岛大学附属医院崂山院区

169

Submit ID:14286

New-ID:PP1111

标题:FSP1 inhibitor icFSP1 sensitizes hepatocellular carcinoma to Lenvatinib by activating

报告人:Congyue Zhang

170

Submit ID:14461

New-ID:PP1112

标题:Basing on clinical-radiologic model to predict the efficacy and prognosis of systemic therapy for hepatocellular carcinoma

报告人:谢婵

单位:中山大学附属第三医院

171

Submit ID:15908

New-ID:PP1116

标题:The efficacy and safety of sintilimab as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative hepatic resection: a prospective, single-arm, multicentric cohort study

报告人:JiaYong Su

172

Submit ID:15913

New-ID:PP1117

标题:The efficacy and safety of camrelizumab as adjuvant therapy in hepatocellular carcinoma patients at high-risk of recurrence after resection

报告人:leiPo Lin

173

Submit ID:15929

New-ID:PP1118

标题:Prognostic factors and an innovative nomogram model for hepatocellular carcinoma patients at high-risk of recurrence after resection with adjuvant PD-1 inhibitors

报告人:JiaYong Su

174

Submit ID:15976

New-ID:PP1119

标题:Immune Checkpoint Inhibitors plus Targeted Therapy for Hepatocellular Carcinoma with Extrahepatic Metastasis: a multicentric retrospective study

报告人:ZhuJian Deng

175

Submit ID:16141

New-ID:PP1120

标题:Radiotherapy with or without Immune checkpoint inhibitors and tyrosine kinase inhibitors in Hepatocellular Carcinoma involving major portal vein and/or inferior vena cava tumor thrombus: a retrospective cohort study

报告人:QianQian Tang

176

Submit ID:15314

New-ID:PP1122

标题:Silibinin suppresses HCC metastasis via regulating Trx-LIN00152-ANGPT1 signaling pathway

报告人:Yuxin Liang

177

Submit ID:15920

New-ID:PP1124

标题:Drug type of adjuvant PD-1 inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: a prospective, multicentric cohort study

报告人:JiaYong Su

178

Submit ID:16033

New-ID:PP1125

标题:Discontinuation of targeted and immunotherapy do not increase the re-bleeding rate after endoscopic treatment for gastroesophageal variceal bleeding in patients with advanced liver cancer

报告人:Wang Huishan

179

Submit ID:15455

New-ID:PP1126

标题:Effect of TACE combined with tislelizumab on patients with advanced liver cancer and influencing factors of prognosis

报告人:Gang Wu

180

Submit ID:15474

New-ID:PP1127

标题:SIRPα promotes tumor immune escape in hepatocellular carcinoma by inducing T cell apoptosis

报告人:Xue Zhang

181

Submit ID:16665

New-ID:PP1129

标题:Research Progress on New Metastatic Mode Vessels That Encapsulate Tumor Clusters Pattern of Hepatocellular Carcinoma

报告人:huiyang fan

182

Submit ID:16372

New-ID:PP1135

标题:Total bile acid is a useful tool for evaluating the risk of portal hypertension in patients with hepatocellular carcinoma who have undergone hepatectomy

报告人:张达利

单位: 中国人民解放军总医院第五医学中心

183

Submit ID:11676

New-ID:PP1141

标题:Novel non-invasive liver reserve and fibrosis signature to evaluate severe post-hepatectomy liver failure in patients with hepatocellular carcinoma

报告人:Feng Zhang

184

Submit ID:14295

New-ID:PP1143

标题:The Safety and Feasibility of the "Pan-Gate Theory" Combined with "Regional Hepatic Inflow Occlusion" in Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Single-Arm, Retrospective Study

报告人:Chenfenglin Yang

185

Submit ID:15607

New-ID:PP1146

标题:Exploration of the therapeutic effect and mechanism of intestinal microbiota transplantation combined with PD-1 inhibitors on liver cancer

报告人:Xiaoxiong Hu

186

Submit ID:15493

New-ID:PP1153

标题:Progression-free survival as a surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma: a multicentric retrospective study

报告人:DaLong Yang

187

Submit ID:14049

New-ID:PP1158

标题:Transplantation versus hepatectomy for Hepatocellular carcinoma ≤2cm: The experience of single center

报告人:xuguang Hu

188

标题:Multi-omics characterization of autophagy-related molecules in liver cancer

报告人:Lin Ye

标题:A CT-based deep learning radiomics scoring system for predicting the prognosis to repeat TACE in patients with hepatocellular carcinoma: A multicenter cohort study

报告人:Yanmei Dai

备注:排名不分先后,按照摘要号进行

如有遗漏或任何问题,请给我们留言~

撰写:Aurora

排版:Aurora

执行:Babel

医脉通是专业的在线医生平台,“感知世界医学脉搏,助力中国临床决策”是平台的使命。医脉通旗下拥有「临床指南」「用药参考」「医学文献王」「医知源」「e研通」「e脉播」等系列产品,全面满足医学工作者临床决策、获取新知及提升科研效率等方面的需求。

本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容,不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的,本平台不承担相关责任。本平台对发布的内容,并不代表同意其描述和观点。若涉及版权问题,烦请权利人与我们联系,我们将尽快处理。

来源:医脉通肿瘤科

相关推荐